EN
  • FR
Contact
  • News
  • Contact
  • CAREERS
LFB Biomanufacturing
  • About
    • About LFB BIOMANUFACTURING
    • Our assets
    • ESCAPE30: our New development strategy
    • THEY APPRECIATE OUR SERVICES
    • About the LFB Group
  • Development services
    • Cell line development and banking
    • EMABling® platform
    • Process development and scale up
  • Manufacturing services
    • GMP manufacturing
  • Innovative facility
  • About LFB BIOMANUFACTURING

    LFB BIOMANUFACTURING is a CDMO specialising in the manufacture of recombinant proteins and monoclonal antibodies.

  • Our assets

    AN EXPERIENCED TEAM, WORKING WITH AGILITY AND UNDERSTANDING CHALLENGES OF BIOLOGICALS: LFB BIOMANUFACTURING has strong assets for your projects

  • ESCAPE30: our New development strategy

    In November 2022 the leadership team  of LFB BIOMANUFACTURING met with aim to precise the strategic path of the company, referred to as ESCAPE30

  • THEY APPRECIATE OUR SERVICES

    Why will you select LFB BIOMANUFACTURING as you preferred partner?

  • About the LFB Group

    LFB group, a pharmaceutical company specialising in biological medicinal products

  • Cell line development and banking

    Two CLD platforms are currently available at LFB BIOMANUFACTURING: a CHO-S  (Life Technology) platform, and EMABling® proprietary platform.

  • EMABling® platform

    A proprietary platform for monoclonal antibodies with enhanced ADCC

  • Process development and scale up

    Services for process development and scale-up

  • GMP manufacturing

    GMP Manufacturing services for recombinant medicinal products

    Flexibility, disposable-oriented, LFB BIOMANUFACTURING’s commitments for tomorrow

    Des médicaments
    commercialisés dans
    plus de 40 pays

    burger

    Accueil › Site map

    • About
      • About LFB BIOMANUFACTURING
      • Our assets
      • ESCAPE30: our New development strategy
      • THEY APPRECIATE OUR SERVICES
      • About the LFB Group
    • Development services
      • Cell line development and banking
      • EMABling® platform
      • Process development and scale up
    • Manufacturing services
      • Innovative facility
      • GMP manufacturing

    Follow us on

    • About
      • About LFB BIOMANUFACTURING
      • Our assets
      • ESCAPE30: our New development strategy
      • THEY APPRECIATE OUR SERVICES
      • About the LFB Group
    • Development services
      • Cell line development and banking
      • EMABling® platform
      • Process development and scale up
    • Manufacturing services
      • Innovative facility
      • GMP manufacturing
    • CAREERS
    • Site map
    • Information notices
     

     

    ×